PHE_Scientific_Provision of T Cell Testing (National Immunisation Programme)
Public Health England (PHE) has awarded a contract to Oxford Immunotec under Lot 2 of the National Microbiology Framework for services to carry T-SPOT® Discovery SARS-CoV-2 assay tests as part of the National Immunisation Programme, a study which PHE has been tasked to perform to evaluate the immune response following COVID-19 vaccines. The provision of T-SPOT Discovery SARS-CoV-2 testing will be used to identify the presence or absence of T cells that are reactive to SARS-CoV-2 peptides. This insight is useful fo...
Buyer
Public Health England
Value
£350,000
Published
5 Oct 2021
Closes
23 Aug 2021
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Selective
Category
Services
Contract starts
31 Aug 2021
Contract ends
31 Jan 2023
CPV classifications
71900000
Laboratory services
Lots
Lot default PHE_Scientific_Provision of T Cell Testing (National Immunisation Programme)
£350,000
Public Health England (PHE) has awarded a contract to Oxford Immunotec under Lot 2 of the National Microbiology Framework for services to carry T-SPOT® Discovery SARS-CoV-2 assay tests as part of the National Immunisation Programme, a study which PHE has been tasked to perform to evaluate the immune response following COVID-19 vaccines. The provision of T-S...
Delivery: United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
5 Oct 2021
Awarded contract notice on Contracts Finder
Award notice · Web page
Order Form - Provision for T-SPOT Discovery SARS-CoV-2 testing [fully executed]_Redacted
Not provided
Order Form - Provision for T-SPOT Discovery SARS-CoV-2 testing [fully executed]_Redacted
Document
Contains public sector information licensed under the Open Government Licence v3.0.